The Asthma Drugs Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The global market for asthma drugs has experienced significant growth. The market size is projected to increase from $23.96 billion in 2024 to $25.17 billion in 2025, with a compound annual growth rate (CAGR) of 5.0%.
In 2029, the global Asthma Drugs market is forecasted to reach a value of $31.98 billion, expanding at a compound annual growth rate (CAGR) of 6.2%.
Download Your Free Sample of the 2025 Asthma Drugs Market Report and Uncover Key Trends Now!The key drivers in the asthma drugs market are:
• Rising levels of air pollution
• Increase in the aging population
• Enhanced healthcare awareness
• Trend towards personalized medicine and biopharmaceutical innovation
The asthma drugs market covered in this report is segmented –
1) By Type Of Asthma: Allergic, Non-Allergic
2) By Asthma Trigger Type: Adult-Onset Asthma, Child-Onset Asthma, Cough-Induced Asthma, Exercise-Induced Asthma, Occupational Asthma, Nocturnal Asthma, Steroid-Resistant Asthma
3) By Therapy: Preventive, Curative
4) By Drug Class: Bronchodilators, Monoclonal Antibodies, Anti-Inflammatory Drugs, Combination Drugs
5) By End-User: Asthma Patients, COPD Patients
The key trends in the asthma drugs market are:
• The market is shifting towards small molecule therapies for asthma treatment.
• The concept of home-based asthma care is becoming more prominent.
• There is a growing trend towards biomarker-guided therapies.
• Collaborations for asthma research are increasing and shaping therapeutic advances in severe asthma.
The major players in the asthma drugs market are:
• Pfizer Inc
North America was the largest region in the asthma drugs market in 2024